Supportive care aims to ensure that patients with acute lymphoblastic leukemia (ALL) derive the most benefit from ALL therapy despite the intensive treatments they undergo. Supportive care should be ...

Acute lymphoblastic leukemia (ALL) may be confused with different types of hematological conditions. Confusion of ALL diagnosis with acute myeloid leukemia (AML), hairy cell leukemia and malignant ...

Precursor B-cell acute lymphoblastic leukemia is a fast-growing leukemia that affects early B cells in bone marrow. It’s both more common and has a better outlook in children. Leukemia is a type of ...

Leukemias are named for the type of blood stem cell affected and how quickly the disease develops and progresses. Acute leukemias grow rapidly, leading to symptoms, and they worsen quickly without ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new targeted antibody therapy, an antibody-drug conjugate, shows promise in eliminating ...

Amir Fathi, MD, discusses one of the biggest nonfinancial barriers to bispecific therapies: the expertise required to safely administer and manage them. Amir Fathi, MD, a leukemia specialist and ...

The BD OneFlow™ AML/MDS Panel is intended for qualitative flow-cytometric immunophenotyping of mature and immature hematopoietic cells populations (lymphoid and myeloid lineages) in bone marrow and ...

Revumenib, an oral targeted therapy for rare leukemias, is projected to be cost-neutral for health plans over 3 years, primarily due to lower administration costs and improved patient quality of life, ...